Overview

Study of Neoadjuvant Chemotherapy of Breast Cancer

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pathological CR rate in breast and lymph nodes of a novel neoadjuvant regimen for invasive breast carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Auxilio Mutuo Cancer Center
Collaborator:
Sanofi